The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
BTMD · Healthcare · Wide moat
On the watchlist
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | OPXS | BTMD | WAT | PDEX |
|---|---|---|---|---|
| Moat Score (0–100) | 80 (highest) | 80 (highest) | 80 (highest) | 79 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 95 (highest) | 69 | 60 | 95 (highest) |
| Pricing power | 21 | — | 98 (highest) | 47 |
| Returns on capital | 82 | 100 (highest) | 97 | 71 |
| Balance-sheet safety | 100 (highest) | 73 | 74 | 81 |
| Capital allocation | 100 (highest) | 80 | 71 | 100 (highest) |
| 174% above value if growth stopped today | No price data | 244% above value if growth stopped today | 143% above value if growth stopped today (largest discount to value if growth stopped today) | |
| Market cap | $68.9M | Not reported | $26.4B | $191M |
| Moat tier | Narrow moat | Wide moat | Wide moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2026 |